Tag: chemotherapy

Women's health physician
April 16, 2024/Cancer

Watching Out for Primary Ovarian Insufficiency

An underdiagnosed condition in patients with cancer

23-CNR-4318382-CQD-Hero-650×450 Dr Hill
December 19, 2023/Cancer/Research

Active Surveillance may be a Feasible Option for a Subset of Patients with Nodular Lymphocyte-Predominant Hodgkin Lymphoma

Large cohort study finds no reduction in survival for patients managed with active surveillance compared to treated patients

23-CNR-3647478-CQD-Hero-650×450 Dr Scott Dr Scarborough
April 27, 2023/Cancer/Genomics

Gene Expression Signature Predicts Patients’ Response to Cisplatin

Research enables precision medicine beyond patients with changed mutational status

Photomicrograph of Acute Myeloblastic Leukemia (AML), a cancer of white blood cell
December 28, 2021/Cancer/Blood Cancers

Uproleselan May Improve Remission, Reduce Side Effects in Patients with Acute Myeloid Leukemia

Study finds drug safe and effective when combined with chemotherapy

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Chimeric antigen receptor (CAR) therapy,
December 14, 2021/Cancer/Blood Cancers

Biomarkers Predict Outcomes of CAR T-Cell Therapy in Patients with Diffuse Large B-Cell Lymphoma

Treatment may be a lifesaving option for patients with relapsed or refractory disease

Scientific illustration of a migrating breast cancer cell – 3d illustration
December 8, 2021/Cancer/Research

Noninvasive Assessment of Sarcopenia May Predict Tolerance to Neo(adjuvant) Chemotherapy in Early-Stage Breast Cancer

Sarcopenia and sarcopenic obesity appear to increase risk of early chemotherapy termination

amyloid_650x450
November 17, 2021/Cancer/Research

Adding Daratumumab to Treatment Regimen May Improve Outcomes in Patients With Immunoglobulin Light-Chain Amyloidosis

Study associates human CD38-targeting antibody with fewer complications

21-CHP-2112520-650×450

Study Supports Single-Dose Rasburicase for Tumor Lysis Syndrome

Findings suggest that a uniform dose can be an effective preventive strategy

vial and syringe

AMH Peptide Mimic May Hold Key to Fertility Preservation in Chemotherapy Patients

Treatment with GnRH agonists may foster a return to menstruation

bladder-cancer_650x450
March 18, 2020/Cancer/Research

Chemo Plus Immunotherapy Shows Promise for Advanced Bladder Cancer

New neoadjuvant treatment regimen offers hope to patients facing a poor prognosis

BackPage 1 of 2Next
Advertisement
Ad